View Item 

Show simple item record

Type‐I interferons suppress microglial production of the lymphoid chemokine, CXCL13

dc.contributor.authorEsen, Niluferen_US
dc.contributor.authorRainey‐barger, Emily K.en_US
dc.contributor.authorHuber, Amanda K.en_US
dc.contributor.authorBlakely, Pennelope K.en_US
dc.contributor.authorIrani, David N.en_US
dc.date.accessioned2014-08-06T16:49:53Z
dc.date.availableWITHHELD_14_MONTHSen_US
dc.date.available2014-08-06T16:49:53Z
dc.date.issued2014-09en_US
dc.identifier.citationEsen, Nilufer; Rainey‐barger, Emily K. ; Huber, Amanda K.; Blakely, Pennelope K.; Irani, David N. (2014). "Typeâ I interferons suppress microglial production of the lymphoid chemokine, CXCL13." Glia 62(9): 1452-1462.en_US
dc.identifier.issn0894-1491en_US
dc.identifier.issn1098-1136en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/108063
dc.publisherWiley Periodicals, Inc.en_US
dc.subject.otherMicrogliaen_US
dc.subject.otherCXCL13en_US
dc.subject.otherType‐I Interferonen_US
dc.subject.otherIRF7en_US
dc.titleType‐I interferons suppress microglial production of the lymphoid chemokine, CXCL13en_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biologyen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/108063/1/glia22692.pdf
dc.identifier.doi10.1002/glia.22692en_US
dc.identifier.sourceGliaen_US
dc.identifier.citedreferencePhares TW, Stohlman SA, Bergmann CC. 2013. Intrathecal humoral immunity to encephalitic RNA viruses. Viruses 5: 732 – 752.en_US
dc.identifier.citedreferenceMagliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Popolo M, Reynolds R, Aloisi F. 2007. Meningeal B‐cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130: 1089 – 1104.en_US
dc.identifier.citedreferenceMazzucchelli L, Blaser A, Kappeler A, Scharli P, Laissue JA, Baggiolini M, Uguccioni M. 1999. BCA‐1 is highly expressed in Helicobacter pylori ‐induced mucosa‐associated lymphoid tissue and gastric lymphoma. J Clin Invest 104: 49 – 54.en_US
dc.identifier.citedreferenceMoser B, Schaerli P, Laetscher P. 2002. CXCR5+ T cells: follicular homing takes center stage in T‐helper‐cell responses. Trends Immunol 23: 250 – 254.en_US
dc.identifier.citedreferenceMueller SN, Hosiawa‐Meagher KA, Konieczny BT, Sullivan BM, Bachmann MF, Locksley RM, Ahmed R, Matloubian M. 2007. Regulation of homeostatic chemokine expression and cell trafficking during immune responses. Science 317: 670 – 674.en_US
dc.identifier.citedreferenceMuller G, Hopken UE, Lipp M. 2003. The impact of CCR7 and CXCR5 on lymphoid organ development and systemic immunity. Immunol Rev 195: 117 – 135.en_US
dc.identifier.citedreferenceNgo VN, Korner H, Gunn MD, Schmidt KN, Riminton DS, Cooper MD, Browning JL, Sedgwick JD, Cyster JG. 1999. Lymphotoxin‐α/β and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J Exp Med 189: 403 – 412.en_US
dc.identifier.citedreferenceNing S, Pagano JS, Barber GN. 2011. IRF7: activation, regulation, modification and function. Genes Immun 12: 399 – 414.en_US
dc.identifier.citedreferencePeters A, Pitcher LA, Sullivan JM, Mitsdoerffer M, Acton SE, Franz B, Wucherpfennig K, Turley S, Carroll MC, Sobel RA, Bettelli E, Kuchroo VK. 2011. Th17 cells induce ectopic lymphoid follicles in central nervous system tissue inflammation. Immunity 35: 986 – 996.en_US
dc.identifier.citedreferencePiccio L, Naismith RT, Trinkaus K, Klein RS, Parks BJ, Lyons JA, Cross AH. 2010. Changes in B‐ and T‐lymphocyte and chemokine levels with rituximab treatment in multiple sclerosis. Arch Neurol 67: 707 – 714.en_US
dc.identifier.citedreferenceProw NA, Irani DN. 2007. The opioid receptor antagonist, naloxone, protects spinal motor neurons in a murine model of alphavirus encephalomyelitis. Exp Neurol 205: 461 – 470.en_US
dc.identifier.citedreferencePublicover J, Gaggar A, Nishimura S, Van Horn CM, Goodsell A, Muench MO, Reinhardt RL, van Rooijen N, Wakil AE, Peters M, Cyster JG, Erle DJ, Rosenthal P, Cooper S, Baron JL. 2013. Age‐dependent hepatic lymphoid organization directs successful immunity to hepatitis B. J Clin Invest 123: 3728 – 3739.en_US
dc.identifier.citedreferenceRagheb S, Li Y, Simon K, Vanhaerents S, Galimberti D, De Riz M, Fenoglio C, Scarpini E, Lisak R. 2011. Multiple sclerosis: BAFF and CXCL13 in cerebrospinal fluid. Mult Scler 17: 819 – 829.en_US
dc.identifier.citedreferenceRainey‐Barger EK, Rumble JM, Lalor SJ, Esen N, Segal BM, Irani DN. 2011. The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system. Brain Behav Immun 25: 922 – 931.en_US
dc.identifier.citedreferenceRamesh G. Borda JT, Dufour J, Kaushal D, Ramamoorthy R, Lackner AA, Philipp MT. 2008. Interaction of the Lyme disease spirochete Borrelia bergdorferi with brain parenchyma elicits inflammatory mediators from glial cells as well as glial and neuronal apoptosis. Am J Pathol 173: 1415 – 1427.en_US
dc.identifier.citedreferenceRangel‐Moreno J, Moyron‐Quiroz JE, Hartson L, Kusser K, Randall TD. 2007. Pulmonary expression of CXC chemokine ligand 13, CC chemokine ligand 19, and CC chemokine ligand 21 is essential for local immunity to influenza. Proc Natl Acad Sci USA 104: 10577 – 10582.en_US
dc.identifier.citedreferenceSchreiber G. 2002. The evolution of transthyretin synthesis in the choroid plexus. Clin Chem Lab Med 40: 1200 – 1210.en_US
dc.identifier.citedreferenceSellebjerg F, Bornsen L, Khademi M, Krakauer M, Olsson T, Frederiksen JL, Sorensen PS. 2009. Increased cerebrospinal fluid concentrations of the chemokine CXCL13 in active MS. Neurology 73: 2003 – 2010.en_US
dc.identifier.citedreferenceSerafini B, Rosicarelli B, Magiozzi R, Aloisi F. 2004. Detection of ectopic B‐cell follicles with germinal centers in meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 14: 164 – 174.en_US
dc.identifier.citedreferenceTucker PC, Griffin DE, Choi S, Bui N, Wesselingh S. 1996. Inhibition of nitric oxide synthesis increases mortality in Sindbis virus encephalitis. J Virol 70: 3972 – 3977.en_US
dc.identifier.citedreferenceTyor WR, Wesselingh S, Levine B, Griffin DE. 1992. Long term intraparenchymal Ig secretion after acute viral encephalitis in mice. J Immunol 149: 4016 – 4020.en_US
dc.identifier.citedreferenceYamamoto K, Nishiumi S, Yang L, Klimatcheva E, Pandina T, Takahashi S, Matsui H, Nakamura M, Zauderer M, Yoshida M, Azuma T. 2014. Anti‐CXCL13 antibody can inhibit the formation of gastric lymphoid follicles induced by Helicobacter infection. Mucosal Immunol. doi: 10.1038/mi.2014.14. [Epub ahead of print]en_US
dc.identifier.citedreferenceYoshie O, Imai T, Nomiyama H. 1997. Novel lymphocyte‐specific CC chemokines and their receptors. J Leukoc Biol 62: 634 – 644.en_US
dc.identifier.citedreferenceZhong X, Wang H, Dai Y, Wu A, Bao J, Xu W, Cheng C, Lu Z, Qiu W, Hu X. 2011. Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica. J Neuroimmunol 241: 104 – 108.en_US
dc.identifier.citedreferenceZlotnik A, Morales J, Hedrick JA. 1999. Recent advances in chemokines and chemokine receptors. Crit Rev Immunol 19: 1 – 47.en_US
dc.identifier.citedreferenceAllen CD, Ansel KM, Low C, Lesley R, Tamamura H, Fujii N, Cyster JG. 2004. Germinal center dark and light zone organization is mediated by CXCR4 and CXCR5. Nat Immunol 5: 943 – 952.en_US
dc.identifier.citedreferenceAloisi F, Columba‐Cabezas S, Franciotta D, Rosicarelli B, Magliozzi R, Reynolds R, Ambrosini E, Salvetti M, Serafini B. 2008. Lymphoid chemokines in chronic neuroinflammation. J Neuroimmunol 198: 106 – 112.en_US
dc.identifier.citedreferenceAnsel KM, Ngo VN, Hyman PL, Luther SA, Forster JD, Sedgwick JD, Browning JL, Lipp M, Cyster JG. 2000. A chemokine‐driven positive feedback loop organizes lymphoid follicles. Nature 406: 309 – 314.en_US
dc.identifier.citedreferenceBagaeva LV, Rao P, Powers JM, Segal BM. 2006. CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis. J Immunol 176: 7676 – 7685.en_US
dc.identifier.citedreferenceBeutner C, Linnartz‐Gerlach B, Schmidt SV, Beyer M, Mallmann MR, Staratschek‐Jox A, Schultzw JL, Neumann H. 2013. Unique transcriptome signature of mouse microglia. Glia 61: 1429 – 1442.en_US
dc.identifier.citedreferenceBrettschneider J, Czerwoniak A, Senel M, Fang L, Kassubek J, Pinkhardt E, Lauda F, Kapfer T, Jesse S, Lehmensiek V, Ludolph AC, Otto M, Tumani H. 2010. The chemokine CXCL13 is a prognostic marker in clinically isolated syndrome (CIS) PLoS One 5: e11986.en_US
dc.identifier.citedreferenceCampbell DJ, Kim CH, Butcher EC. 2003. Chemokines in the systemic organization of immunity. Immunol Rev 195: 58 – 71.en_US
dc.identifier.citedreferenceCucak H, Yrlid U, Reizis B, Kalinke U, Johansson‐Lindbom B. 2009. Type I interferon signaling in dendritic cells stimulates the development of lymph node‐resident T follicular helper cells. Immunity 31: 491 – 501.en_US
dc.identifier.citedreferenceCufi P, Dragin N, Ruhlmann N, Weiss JM, Fadel E, Serraf A, Berrih‐Aknin S, Le Panse R. 2013. Central role of interferon‐beta in thymic events leading to myasthenia gravis. J Autoimmun. http://dx.doi.orp/10.1016/j.aut.2013.12.016.en_US
dc.identifier.citedreferenceDerecki NC, Cardani AN, Yang CH, Quinnies KM, Crihfield A, Lynch KR, Kipnis J. 2010. Regulation of learning and memory by meningeal immunity: a key role for IL‐4. J Exp Med 207: 1067 – 1080.en_US
dc.identifier.citedreferenceEsen N, Kielian T. 2005. Recognition of staphylococcus aureus‐derived peptidoglycan but not intact bacteria is mediated by CD14 in microglia. J Neuroimmunol 170: 93 – 104.en_US
dc.identifier.citedreferenceForster R, Matis AE, Kremmer E, Wolf E, Brem G, Lipp M. 1996. A putative chemokine receptor, BLR1, directs B cell migration to defined lymphoid organs and specific anatomic compartments of the spleen. Cell 87: 1037 – 1047.en_US
dc.identifier.citedreferenceFu Y‐X, Chaplin DD. 1999. Development and maturation of secondary lymphoid tissues. Annu Rev Immunol 17: 399 – 433.en_US
dc.identifier.citedreferenceHjelmstrom P. 2001. Lymphoid neogenesis: de novo formation of lymphoid tissue in chronic inflammation through expression of homing chemokines. J Leukoc Biol 69: 331 – 339.en_US
dc.identifier.citedreferenceHonda K, Yanai H, Negishi H, Asagiri M, Sato M, Mizutani T, Shimada N, Ohba Y, Takaoka A, Yoshida N, Taniguchi T. 2005. IRF‐7 is the master regulator of type‐I interferon‐dependent immune responses. Nature 434: 772 – 777.en_US
dc.identifier.citedreferenceIrani DN, Prow NA. 2007. Neuroprotective interventions targeting detrimental host immune responses protect mice from fatal alphavirus encephalitis. J Neuropathol Exp Neurol 66: 533 – 544.en_US
dc.identifier.citedreferenceKhademi M, Kockum I, Andersson ML, Iacobaeus E, Brundin L, Sellebjerg F, Hillert J, Piehl F, Olsson T. 2011. Cerebrospinal fluid CXCL13 in multiple sclerosis: A suggestive prognostic marker for the disease course. Mult Scler 17: 335 – 343.en_US
dc.identifier.citedreferenceKrumbholz M, Theil D, Cepok S, Hemmer B, Kivisakk P, Ransohoff RM, Hofbauer M, Farina C, Derfuss T, Hartle C, Newcombe J, Hohlfeld R, Meinl E. 2006. Chemokines in multiple sclerosis: CXCR12 and CXCR13 up‐regulation is differentially linked to CNS immune cell recruitment. Brain 129: 200 – 211.en_US
dc.identifier.citedreferenceLalor SJ, Segal BM. 2010. Lymphoid chemokines in the CNS. J Neuroimmunol 224: 56 – 61.en_US
dc.identifier.citedreferenceLegler DF, Loetscher M, Roos R, Clark‐Lewis I, Baggiolini M, Moser B. 1998. B‐cell attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/CXCR5. J Exp Med 187: 655 – 660.en_US
dc.identifier.citedreferenceLiang XH, Goldman JE, Jiang HH, Levine B. 1999. Resistance of interleukin‐1β‐deficient mice to fatal Sindbis virus encephalitis. J Virol 73: 2563 – 2567.en_US
dc.identifier.citedreferenceLuther SA, Lopez T, Bai W, Hanahan D, Cyster JG. 2000. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin‐dependent lymphoid neogenesis. Immunity 12: 471 – 481.en_US
dc.identifier.citedreferenceMackay F, Browning JL. 1998. Turning off follicular dendritic cells. Nature 395: 26 – 27.en_US
dc.identifier.citedreferenceMcManus CM, Liu JS, Hahn MT, Hua LL, Brosnan CF, Berman JW, Lee SC. 2000. Differential induction of chemokines in human microglia by type I and type II interferons. Glia 29: 273 – 280.en_US
dc.identifier.citedreferenceMagliozzi R, Columba‐Cabezas S, Serafini B, Aloisi F. 2004. Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle‐like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. J Neuroimmunol 148: 11 – 23.en_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
glia22692.pdf
Size:
708.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.